These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 21531695

  • 21. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I, De Leo A, D'Angelo E, Rosa-Rosa JM, Corominas M, Gonzalez A, Palacios J, Prat J.
    Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
    [Abstract] [Full Text] [Related]

  • 22. Undifferentiated carcinoma of the endometrium.
    Altrabulsi B, Malpica A, Deavers MT, Bodurka DC, Broaddus R, Silva EG.
    Am J Surg Pathol; 2005 Oct; 29(10):1316-21. PubMed ID: 16160474
    [Abstract] [Full Text] [Related]

  • 23. Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review.
    Kamal M, Atwi D, Pang H, Li S, Hassell L.
    Int J Surg Pathol; 2023 Dec; 31(8):1526-1531. PubMed ID: 36843546
    [Abstract] [Full Text] [Related]

  • 24. Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma.
    Stewart CJ, Crook ML.
    Hum Pathol; 2015 Oct; 46(10):1514-20. PubMed ID: 26239622
    [Abstract] [Full Text] [Related]

  • 25. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
    Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE.
    Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
    [Abstract] [Full Text] [Related]

  • 26. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB.
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [Abstract] [Full Text] [Related]

  • 27. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK, Zhang HT, Sun YC, Wu LY.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [Abstract] [Full Text] [Related]

  • 28. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
    Rubatt JM, Slomovitz BM, Burke TW, Broaddus RR.
    Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
    [Abstract] [Full Text] [Related]

  • 29. Cytologic scoring of endometrioid adenocarcinoma of the endometrium.
    Nishimura Y, Watanabe J, Jobo T, Hattori M, Arai T, Kuramoto H.
    Cancer; 2005 Feb 25; 105(1):8-12. PubMed ID: 15597380
    [Abstract] [Full Text] [Related]

  • 30. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary.
    Nishimura N, Hachisuga T, Yokoyama M, Iwasaka T, Kawarabayashi T.
    J Obstet Gynaecol Res; 2005 Apr 25; 31(2):120-6. PubMed ID: 15771637
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
    Garuti G, De Giorgi O, Sambruni I, Cellani F, Luerti M.
    Gynecol Oncol; 2001 Jun 25; 81(3):408-13. PubMed ID: 11371130
    [Abstract] [Full Text] [Related]

  • 35. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF, Kurman RJ.
    Verh Dtsch Ges Pathol; 1997 Jun 25; 81():228-32. PubMed ID: 9474874
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA.
    Int J Gynecol Pathol; 2019 Jan 25; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
    [Abstract] [Full Text] [Related]

  • 39. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
    Hoang LN, Lee YS, Karnezis AN, Tessier-Cloutier B, Almandani N, Coatham M, Gilks CB, Soslow RA, Stewart CJ, Köbel M, Lee CH.
    Histopathology; 2016 Oct 25; 69(4):560-9. PubMed ID: 27101785
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.